title: Dihydroergotoxine (hydergine) to prevent cyclosporine nephrotoxicity in kidney transplant recipients.
authors.affiliation: Department of Internal Medicine, University Hospital Rotterdam-Dijkzigt, The Netherlands.
authors.forename: H H
authors.initials: HH
authors.lastname: Vincent
authors.forename: G J
authors.initials: GJ
authors.lastname: Wenting
authors.forename: J
authors.initials: J
authors.lastname: Jeekel
authors.forename: M A
authors.initials: MA
authors.lastname: Schalekamp
authors.forename: W
authors.initials: W
authors.lastname: Weimar
mesh_terms: D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D006084:Graft Rejection; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D003524:Cyclosporins; D004088:Dihydroergotoxine; D011241:Prednisone; D006854:Hydrocortisone